209 related articles for article (PubMed ID: 23979751)
1. Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria.
Orjuela-Sánchez P; Ong PK; Zanini GM; Melchior B; Martins YC; Meays D; Frangos JA; Carvalho LJ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5462-71. PubMed ID: 23979751
[TBL] [Abstract][Full Text] [Related]
2. Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.
Clemmer L; Martins YC; Zanini GM; Frangos JA; Carvalho LJ
Antimicrob Agents Chemother; 2011 Apr; 55(4):1383-90. PubMed ID: 21220531
[TBL] [Abstract][Full Text] [Related]
3. The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.
Dai M; Freeman B; Bruno FP; Shikani HJ; Tanowitz HB; Weiss LM; Reznik SE; Stephani RA; Desruisseaux MS
Life Sci; 2012 Oct; 91(13-14):687-92. PubMed ID: 22820174
[TBL] [Abstract][Full Text] [Related]
4. Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine.
Cabrales P; Zanini GM; Meays D; Frangos JA; Carvalho LJ
Am J Pathol; 2010 Mar; 176(3):1306-15. PubMed ID: 20110412
[TBL] [Abstract][Full Text] [Related]
5. Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine.
Ong PK; Moreira AS; Daniel-Ribeiro CT; Frangos JA; Carvalho LJM
Sci Rep; 2018 Oct; 8(1):15957. PubMed ID: 30374028
[TBL] [Abstract][Full Text] [Related]
6. Slow and continuous delivery of a low dose of nimodipine improves survival and electrocardiogram parameters in rescue therapy of mice with experimental cerebral malaria.
Martins YC; Clemmer L; Orjuela-Sánchez P; Zanini GM; Ong PK; Frangos JA; Carvalho LJ
Malar J; 2013 Apr; 12():138. PubMed ID: 23617605
[TBL] [Abstract][Full Text] [Related]
7. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.
Solomon W; Wilson NO; Anderson L; Pitts S; Patrickson J; Liu M; Ford BD; Stiles JK
J Neuroinflammation; 2014 Jan; 11():9. PubMed ID: 24433482
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase dysfunction contributes to impaired cerebroarteriolar reactivity in experimental cerebral malaria.
Ong PK; Melchior B; Martins YC; Hofer A; Orjuela-Sánchez P; Cabrales P; Zanini GM; Frangos JA; Carvalho LJ
PLoS Pathog; 2013; 9(6):e1003444. PubMed ID: 23818850
[TBL] [Abstract][Full Text] [Related]
9. NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria.
Bertinaria M; Orjuela-Sanchez P; Marini E; Guglielmo S; Hofer A; Martins YC; Zanini GM; Frangos JA; Gasco A; Fruttero R; Carvalho LJ
J Med Chem; 2015 Oct; 58(19):7895-9. PubMed ID: 26367273
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.
Wilson NO; Solomon W; Anderson L; Patrickson J; Pitts S; Bond V; Liu M; Stiles JK
PLoS One; 2013; 8(4):e60898. PubMed ID: 23630573
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of reactive oxygen and nitrogen intermediates in Plasmodium berghei infected mice after rescue therapy with chloroquine or artemether.
Prada J; Müller S; Bienzle U; Kremsner PG
J Antimicrob Chemother; 1996 Jul; 38(1):95-102. PubMed ID: 8858461
[TBL] [Abstract][Full Text] [Related]
12. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
Yalcin O; Oronsky B; Carvalho LJ; Kuypers FA; Scicinski J; Cabrales P
Malar J; 2015 May; 14():218. PubMed ID: 26017006
[TBL] [Abstract][Full Text] [Related]
13. Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice.
Zanini GM; Cabrales P; Barkho W; Frangos JA; Carvalho LJ
J Neuroinflammation; 2011 Jun; 8():66. PubMed ID: 21649904
[TBL] [Abstract][Full Text] [Related]
14. Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester.
Gardiner SM; Compton AM; Kemp PA; Bennett T
Br J Pharmacol; 1990 Nov; 101(3):632-9. PubMed ID: 2127552
[TBL] [Abstract][Full Text] [Related]
15. S1P is associated with protection in human and experimental cerebral malaria.
Finney CA; Hawkes CA; Kain DC; Dhabangi A; Musoke C; Cserti-Gazdewich C; Oravecz T; Liles WC; Kain KC
Mol Med; 2011; 17(7-8):717-25. PubMed ID: 21556483
[TBL] [Abstract][Full Text] [Related]
16. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
[TBL] [Abstract][Full Text] [Related]
17. Artemisone effective against murine cerebral malaria.
Waknine-Grinberg JH; Hunt N; Bentura-Marciano A; McQuillan JA; Chan HW; Chan WC; Barenholz Y; Haynes RK; Golenser J
Malar J; 2010 Aug; 9():227. PubMed ID: 20691118
[TBL] [Abstract][Full Text] [Related]
18. Investigation of hydrogen sulfide gas as a treatment against P. falciparum, murine cerebral malaria, and the importance of thiolation state in the development of cerebral malaria.
DellaValle B; Staalsoe T; Kurtzhals JA; Hempel C
PLoS One; 2013; 8(3):e59271. PubMed ID: 23555646
[TBL] [Abstract][Full Text] [Related]
19. Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053).
Appleton JP; Scutt P; Dixon M; Howard H; Haywood L; Havard D; Hepburn T; England T; Sprigg N; Woodhouse LJ; Wardlaw JM; Montgomery AA; Pocock S; Bath PM;
Int J Stroke; 2019 Feb; 14(2):191-206. PubMed ID: 28762896
[TBL] [Abstract][Full Text] [Related]
20. Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria.
Du Y; Chen G; Zhang X; Yu C; Cao Y; Cui L
Int Immunopharmacol; 2017 Jul; 48():219-230. PubMed ID: 28531845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
